Dimebon improves learning in animals with experimental Alzheimer's disease

被引：57
|
作者：
Lermontova, NN [1 ]
Lukoyanov, NV [1 ]
Serkova, TP [1 ]
Lukoyanova, EA [1 ]
Bachurin, SO [1 ]
机构：
[1] Russian Acad Sci, Inst Physiol Act Subst, Neurochem Lab, Chernogolovka 142432, Moscow Region, Russia
来源：
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2000年 / 129卷 / 06期
基金：
俄罗斯基础研究基金会;
关键词：
dimebon; H-1 receptor inhibitor; tacrine; AF64A; avoidance conditioning; rats;
D O I：
10.1007/BF02434871
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Systemic administration of antihistamine drug dimebon improves active avoidance conditioning in rats with chronic partial deprivation of cerebral cholinergic functions caused by intracerebroventricular injections of AF64A. The effects of dimebon on learning are similar to those of tacrine used in the treatment of Alzheimer's disease.
引用
收藏
页码：544 / 546
页数：3
相关论文
共 50 条
  • [1] Dimebon improves learning in animals with experimental Alzheimer's disease
    N. N. Lermontova
    N. V. Lukoyanov
    T. P. Serkova
    E. A. Lukoyanova
    S. O. Bachurin
    Bulletin of Experimental Biology and Medicine, 2000, 129 : 544 - 546
  • [2] Dimebon improves cognitive function in people with mild to moderate Alzheimer's disease COMMENT
    Gauthier, Serge
    EVIDENCE-BASED MENTAL HEALTH, 2009, 12 (01) : 21 - 21
  • [3] DIMEBON AS A POTENTIAL THERAPY FOR ALZHEIMER'S DISEASE
    Doody, Rachelle S.
    CNS SPECTRUMS, 2009, 14 (08) : 14 - 16
  • [4] Dimebon in Alzheimer's disease: old drug for new indication
    Burns, Alistair
    Jacoby, Robin
    LANCET, 2008, 372 (9634): : 179 - 180
  • [5] Transgenic models of Alzheimer's disease: Learning from animals
    Spires T.L.
    Hyman B.T.
    NeuroRX, 2005, 2 (3): : 423 - 437
  • [6] Preclinical study of dimebon on β-amyloid-mediated neuropathology in Alzheimer's disease
    Wang, Jun
    Ferruzzi, Mario G.
    Varghese, Merina
    Qian, Xianjuan
    Cheng, Alice
    Xie, Mathew
    Zhao, Wei
    Ho, Lap
    Pasinetti, Giulio M.
    MOLECULAR NEURODEGENERATION, 2011, 6
  • [7] Preclinical study of dimebon on β-amyloid-mediated neuropathology in Alzheimer's disease
    Jun Wang
    Mario G Ferruzzi
    Merina Varghese
    Xianjuan Qian
    Alice Cheng
    Mathew Xie
    Wei Zhao
    Lap Ho
    Giulio M Pasinetti
    Molecular Neurodegeneration, 6
  • [8] Dimebon improves patient function and decreases caregiver assistance time in Alzheimer's disease: One-year clinical trial results
    Doody, Rachelle S.
    Gavrilova, Svetlana
    Aisen, Paul
    Hirmand, Mohammad
    Sano, Mary
    NEUROLOGY, 2008, 70 (11) : A98 - A98
  • [9] [11C]Dimebon as a new PET agent for imaging of Alzheimer's disease and Huntington's disease
    Gao, Mingzhang
    Wang, Min
    Hutchins, Gary
    Zheng, Qi-Huang
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [10] Cathepsin B Improves -Amyloidosis and Learning and Memory in Models of Alzheimer's Disease
    Embury, Christine M.
    Dyavarshetty, Bhagyalaxmi
    Lu, Yaman
    Wiederin, Jayme L.
    Ciborowski, Pawel
    Gendelman, Howard E.
    Kiyota, Tomomi
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 (02) : 340 - 352
12345